Exact Sciences
EXAS
$65.35
Share price
-8.40%
Change (1 day)
-1.13%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Number of shares outstanding for Exact Sciences (EXAS)
Number of shares outstanding as of April 2024 : 180,649,000
According to Exact Sciences's latest financial reports and stock price the company's current number of shares outstanding is 180,649,000. At the end of 2023 the company had 180,649,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Exact Sciences from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.18 B | 1.73% |
| 2022 | 0.17 B | 2.98% |
| 2021 | 0.17 B | 10.21% |
| 2020 | 0.15 B | 11.84% |
| 2019 | 0.13 B | 13.76% |
| 2018 | 0.12 B | 2.53% |
| 2017 | 0.11 B | 9.77% |
| 2016 | 0.10 B | 13.35% |
| 2015 | 96.4 M | 13.77% |
| 2014 | 84.73 M | 19.75% |
| 2013 | 70.75 M | 11.28% |
| 2012 | 63.58 M | 21.24% |
| 2011 | 52.44 M | 30.6% |
| 2010 | 40.15 M | 14.95% |
| 2009 | 34.93 M | 28.27% |
| 2008 | 27.23 M | 0.8% |
| 2007 | 27.01 M | 1.71% |
| 2006 | 26.56 M | 1.03% |
| 2005 | 26.29 M | 0.59% |
| 2004 | 26.13 M | 37.39% |
| 2003 | 19.02 M | 2.55% |
| 2002 | 18.55 M | 3.71% |
| 2001 | 17.88 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 2,507,200,000 | 1,287.88% | 🇫🇷 France |
 Veracyte VCYT | 72,804,770 | -59.70% | 🇺🇸 USA |
 Antares Pharma ATRS | 165,560,000 | -8.35% | 🇺🇸 USA |
 Myriad Genetics MYGN | 81,900,000 | -54.66% | 🇺🇸 USA |
 Biocept
BIOC | 1,036,529 | -99.43% | 🇺🇸 USA |